These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24317633)

  • 1. Kinetic studies on the oxidation of oxyhemoglobin by biologically active iron thiosemicarbazone complexes: relevance to iron-chelator-induced methemoglobinemia.
    Basha MT; Rodríguez C; Richardson DR; Martínez M; Bernhardt PV
    J Biol Inorg Chem; 2014 Mar; 19(3):349-57. PubMed ID: 24317633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetico-mechanistic studies on methemoglobin generation by biologically active thiosemicarbazone iron(III) complexes.
    Basha MT; Bordini J; Richardson DR; Martinez M; Bernhardt PV
    J Inorg Biochem; 2016 Sep; 162():326-333. PubMed ID: 27079328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect.
    Quach P; Gutierrez E; Basha MT; Kalinowski DS; Sharpe PC; Lovejoy DB; Bernhardt PV; Jansson PJ; Richardson DR
    Mol Pharmacol; 2012 Jul; 82(1):105-14. PubMed ID: 22508546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic dithiocarbazate iron chelators: Fe coordination chemistry and biological activity.
    Basha MT; Chartres JD; Pantarat N; Ali MA; Mirza AH; Kalinowski DS; Richardson DR; Bernhardt PV
    Dalton Trans; 2012 Jun; 41(21):6536-48. PubMed ID: 22362375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.
    Stefani C; Jansson PJ; Gutierrez E; Bernhardt PV; Richardson DR; Kalinowski DS
    J Med Chem; 2013 Jan; 56(1):357-70. PubMed ID: 23276209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs.
    Plamthottam S; Sun D; Van Valkenburgh J; Valenzuela J; Ruehle B; Steele D; Poddar S; Marshalik M; Hernandez S; Radu CG; Zink JI
    J Biol Inorg Chem; 2019 Aug; 24(5):621-632. PubMed ID: 31250199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.
    Richardson DR; Sharpe PC; Lovejoy DB; Senaratne D; Kalinowski DS; Islam M; Bernhardt PV
    J Med Chem; 2006 Nov; 49(22):6510-21. PubMed ID: 17064069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study.
    Popović-Bijelić A; Kowol CR; Lind ME; Luo J; Himo F; Enyedy EA; Arion VB; Gräslund A
    J Inorg Biochem; 2011 Nov; 105(11):1422-31. PubMed ID: 21955844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically active thiosemicarbazone Fe chelators and their reactions with ferrioxamine B and ferric EDTA; a kinetic study.
    Bernhardt PV; Martínez M; Rodríguez C; Vazquez M
    Dalton Trans; 2012 Feb; 41(7):2122-30. PubMed ID: 22180864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
    Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV
    J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues.
    Bernhardt PV; Caldwell LM; Chaston TB; Chin P; Richardson DR
    J Biol Inorg Chem; 2003 Nov; 8(8):866-80. PubMed ID: 14564555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
    Kalinowski DS; Yu Y; Sharpe PC; Islam M; Liao YT; Lovejoy DB; Kumar N; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Jul; 50(15):3716-29. PubMed ID: 17602603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity.
    Kovacevic Z; Kalinowski DS; Lovejoy DB; Quach P; Wong J; Richardson DR
    Curr Drug Deliv; 2010 Jul; 7(3):194-207. PubMed ID: 20507267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex forming competition and in-vitro toxicity studies on the applicability of di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone (Dp44mT) as a metal chelator.
    Gaál A; Orgován G; Polgári Z; Réti A; Mihucz VG; Bősze S; Szoboszlai N; Streli C
    J Inorg Biochem; 2014 Jan; 130():52-8. PubMed ID: 24176919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia.
    Kunos CA; Radivoyevitch T; Ingalls ST; Hoppel CL
    Future Oncol; 2012 Feb; 8(2):145-50. PubMed ID: 22335579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
    Opletalová V; Kalinowski DS; Vejsová M; Kunes J; Pour M; Jampílek J; Buchta V; Richardson DR
    Chem Res Toxicol; 2008 Sep; 21(9):1878-89. PubMed ID: 18698850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 2-benzoylpyridine thiosemicarbazones in a dimeric system: structure-activity relationship studies on their anti-proliferative and iron chelation efficacy.
    Lukmantara AY; Kalinowski DS; Kumar N; Richardson DR
    J Inorg Biochem; 2014 Dec; 141():43-54. PubMed ID: 25217717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the reaction of 2-formylpyridine thiosemicarbazone and its iron and copper complexes with biological systems.
    Antholine W; Knight J; Whelan H; Petering DH
    Mol Pharmacol; 1977 Jan; 13(1):89-98. PubMed ID: 834188
    [No Abstract]   [Full Text] [Related]  

  • 19. Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9.
    Debebe Z; Ammosova T; Breuer D; Lovejoy DB; Kalinowski DS; Kumar K; Jerebtsova M; Ray P; Kashanchi F; Gordeuk VR; Richardson DR; Nekhai S
    Mol Pharmacol; 2011 Jan; 79(1):185-96. PubMed ID: 20956357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equilibrium and kinetic studies of iron(II) and iron(III) complexes of some alpha (N)-heterocyclic thiosemicarbazones. Reduction of the iron(III) complexes of 2-formylpyridine thiosemicarbazone and 2-acetylpyridine thiosemicarbazone by cellular thiol-like reducing agents.
    Borges RH; Paniago E; Beraldo H
    J Inorg Biochem; 1997 Mar; 65(4):267-75. PubMed ID: 9046107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.